Ozempic is safe and effective when used as indicated for the treatment of adults with type 2 diabetes to lower blood sugar, along with diet and exercise, reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who also have heart disease, and lower the risk of worsening kidney disease, kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults with type 2 diabetes who also have chronic kidney disease
These results are consistent with our observation of increased lipid peroxidation products in ESA-treated cells (Fig
Smaller meals, thorough chewing, and avoiding carbonated beverages help manage this symptom
In the UK, from early 2024 to early 2025, approximately 1.6 million adults in England, Wales, and Scotland used GLP-1 class drugs for weight loss, including semaglutide drugs like 'Wegovy' and 'Ozempic', or tirzepatide drugs like 'Mounjaro'
Nature 443:289295 Friedman JM, Halaas JL (1998) Leptin and the regulation of body weight in mammals